ARS Pharmaceuticals | ARS:年度报告
04/27 04:10
ARS Pharmaceuticals | DEFA14A:其他
04/27 04:09
ARS Pharmaceuticals | DEF 14A:股东委托书决议
04/27 04:08
ARS Pharmaceuticals | 4:持股变动声明-高管 Tanimoto Sarina
04/25 06:24
ARS Pharmaceuticals | 4:持股变动声明-高管 Lowenthal Richard E
04/25 06:19
ARS Pharmaceuticals | 4:持股变动声明-高管 Tanimoto Sarina
04/23 07:27
ARS Pharmaceuticals | 4:持股变动声明-高管 Lowenthal Richard E
04/23 07:27
ARS Pharmaceuticals | 4:持股变动声明-高管 Tanimoto Sarina
04/18 06:45
ARS Pharmaceuticals | 4:持股变动声明-高管 Lowenthal Richard E
04/18 06:45
ARS Pharmaceuticals | 4:持股变动声明-高管 Tanimoto Sarina
04/11 05:43
ARS Pharmaceuticals | 4:持股变动声明-高管 Lowenthal Richard E
04/11 05:38
ARS Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(11.3%),Peter Kolchinsky(11.3%)等
03/30 04:18
ARS Pharmaceuticals | 4:持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.
03/28 07:40
ARS Pharmaceuticals | 4:持股变动声明-高管 Lowenthal Richard E
03/27 06:50
ARS Pharmaceuticals | 4:持股变动声明-高管 Tanimoto Sarina
03/27 06:50
ARS Pharmaceuticals | 10-K:年度报表
03/22 10:22
ARS Pharmaceuticals | 4:持股变动声明-高管 Lowenthal Richard E
03/22 09:52
ARS Pharmaceuticals | 4:持股变动声明-高管 Tanimoto Sarina
03/22 09:52
ARS Pharmaceuticals | S-8:员工福利计划证券登记
03/22 05:13
ARS Pharmaceuticals | 8-K:ARS Pharmicals提供最新业务并报告2023年第四季度和全年财务业绩
03/22 04:10
暂无数据
暂无数据